Approval · Notice of Compliance 11256 · 2010
MARINOL: Notice of Compliance 11256
Issued April 19, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11256
- Date
- April 19, 2010
- Company
- Abbott Products Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiemetic
Products in this notice
Medicinal ingredients
- DRONABINOL 2.5 MG per CAP
- DRONABINOL 5 MG per CAP